Sophie Winandy, Executive Director of Medical Imaging at ICON explores the benefits of AI and how it can be integrated throughout medical imaging within clinical trials.   Artificial intelligence (AI) is rapidly taking hold in the healthcare sector1, including in medical imaging, where AI often targets screening, patient eligibility, detection and disease response (Figure 1). […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!